SCHEMBL5506599

SCHEMBL5506599

Cc1cccc2oc(C(=O)NC3CC3)c(C)c12

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.62
RAB9A P51151 7/20 0.62
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MCHR1 Q99705 1/20 0.43
PKM P14618 1/20 0.43
POLB P06746 1/20 0.43
MMP2 P08253 1/20 0.42
MMP13 P45452 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1156414 0.81 NPC1 (0.90) NPC1RAB9ATDP1ALDH1A1MEN1
SCHEMBL3612485 0.75 EDNRA (0.66) NPC1RAB9AALDH1A1KDM4EHPGD
SCHEMBL27294093 0.74 NPC1 (0.54) NPC1RAB9AALDH1A1KDM4EHSD17B10
SCHEMBL28171584 0.73 EDNRA (0.47) NPC1RAB9AKDM4EHSD17B10MAPT
SCHEMBL4950101 0.73 EDNRA (0.47) NPC1RAB9AALDH1A1KDM4EHPGD
SCHEMBL936525 0.73 TAS1R3 (0.57) NPC1RAB9AALDH1A1HPGDMEN1
SCHEMBL1987660 0.72 TAS1R3 (0.64) NPC1RAB9AALDH1A1KDM4EHPGD
SCHEMBL3608518 0.69 RAB9A (0.76) NPC1RAB9AALDH1A1KDM4EHPGD
SCHEMBL457993 0.68 NPC1 (0.84) NPC1RAB9AALDH1A1KDM4EHPGD
SCHEMBL21593332 0.68 PPIA (0.51) NPC1RAB9AALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776106-A1 HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS Vertex Pharmaceuticals Incorporated (US) 2007-04-25 EP disclosed
WO-2006010008-A1 HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-01-26 WO disclosed